drugset / Trial / NCT01097980

Trazodone for SSRI-sexual Dsyfunction

NCT01097980

RandomizedSingle-groupQuadruple-blindTreatment

Summary

The aim of this study is to investigate the efficacy of trazodone in the treatment of selective serotonin reuptake inhibitor(s) associated sexual dysfunction. The secondary domains assessed were the relationship between 5-HT2A polymorphism and treatment efficacy.

Timeline

Start
2010-04
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Trazodone Small molecule 100 mg